Trusted Platform for Named Patient Medicine Access

Ikris Health Plus is a trusted named patient access platform designed to support healthcare professionals, patients and institutions seeking regulated access to speciality medicines. Developed by Ikris Pharma Network, the platform focuses on patient-specific medicine access when conventional supply channels are unavailable. It facilitates access to recently approved oncology, rare disease and speciality medicines through legally permitted named patient programs. Every request requires valid preions, medical justification and complete regulatory documentation to ensure ethical and compliant sourcing. Ikris Health Plus collaborates closely with physicians, hospitals and healthcare partners to align clinical needs with appropriate supply options. Medicines are sourced from authorised manufacturers and verified suppliers following GDP and international quality standards. With operational presence in Belgium and Bulgaria, the platform supports EU GDP-compliant sourcing, storage and global distribution. By emphasising transparency, traceability and regulatory adherence, Ikris Health Plus builds confidence among healthcare stakeholders while supporting timely access to critical therapies worldwide.